Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

PTC Therapeutics Company Profile (NASDAQ:PTCT)

Consensus Ratings for PTC Therapeutics (NASDAQ:PTCT) (?)
Ratings Breakdown: 1 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.89)
Consensus Price Target: $32.06 (15.33% upside)

Current Analysts' Coverage Summary for PTC Therapeutics (NASDAQ:PTCT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/22/2014Bank of AmericaInitiated CoverageBuy$37.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014BarclaysInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
7/7/2014Roth CapitalInitiated CoverageBuy$34.00ViewTweet This Rating  Share This Rating on StockTwits
5/23/2014Credit SuisseBoost Price Target$35.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
5/22/2014ZacksUpgradeUnderperform -> Neutral$15.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014B. RileyInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
1/30/2014JPMorgan Chase & Co.UpgradeOverweightViewTweet This Rating  Share This Rating on StockTwits
11/8/2013WedbushBoost Price TargetOutperform$31.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013Evercore PartnersBoost Price TargetOverweight$30.00 -> $34.50ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Jefferies GroupBoost Price Target$25.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Cowen and CompanyInitiated CoverageOutperform$33.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2012 forward)